Record breaking quarter across specialty divisions
TEL AVIV, Israel--(BUSINESS WIRE)-- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and chemicals company, today reported its financial results for the first quarter ended March 31, 2021. Consolidated sales of $1,510 million were up $191 million. Operating income of $185 million was up $53 million. Net income of $135 million was up $75 million, and EBITDA of $295 million was up $45 million.
“In the first quarter of 2021, ICL delivered quarterly sales of $1.5 billion for the first time since 2014. We executed on our growth strategy, which resulted in record results across all our specialty businesses. We also saw continued strong cash generation and margin expansion, which was supported by improved market fundamentals," said Raviv Zoller, president and CEO of ICL.
"Specifically, our Industrial Products division reported record sales and EBITDA – as it continued to grow, due to a shift to long-term contracts – and saw strong demand returning to most of its end-markets. Phosphate and Food Specialties helped to deliver record sales and EBITDA, which was up more than 60%, following 18 months of steady growth – driven by product innovation and cost efficiencies – as the business continued to shift to specialties. Innovative Ag Solutions also had a remarkable quarter, with double digit growth and higher margins. This business benefitted from our unified sales and marketing organization, as well as from higher volumes and improved product mix. For the first quarter, IAS profitability was greater than for all of 2019, and we are poised for further growth as we expand our footprint in Brazil,” concluded Zoller.
Due to improved market conditions, combined with prompt execution in the first quarter of 2021, the probability of the company achieving the high-end of its previous guidance range has risen considerably. As a result, ICL is raising its expectations for full year adjusted EBITDA to a range of $1,090 million to $1,175 million. (1a)
Key Financials
First Quarter 2021
US$M Ex. per share data
1Q’21
1Q’20
YoY Change
Sales
$1,510
$1,319
14%
Gross profit
$495
$400
24%
Gross margin
32.8%
30.3%
250 bps
Operating income
$185
$132
40%
Operating margin
12.3%
10.0%
230 bps
Net income attributable to shareholders
$135
$60
125%
EBITDA*
$295
$250
18%
EBITDA margin
19.5%
19.0%
50 bps
Diluted earnings per share
11.00¢
5.00¢
120%
Dividend per share
5.25¢
2.30¢
128%
Cash flows from operating activities
$206
$166
* EBITDA is a non-GAAP financial measure; see reconciliation tables in appendix.
Industrial Products
First quarter 2021
Highlights
Potash
Phosphate Solutions
Innovative Ag Solutions
Financial Items
Financing Expenses
Net financing expenses for the first quarter of 2021 were $20 million vs. $52 million in the same quarter last year. The decrease was mainly due to lower expenses related to net exchange rate differences and hedging transactions.
Tax Expenses
Tax expenses in the first quarter of 2021 and 2020 were $23 million and $20 million, reflecting an effective tax rate of approximately 14% and 25%, respectively. The lower rate was mainly due to the devaluation of the Israeli shekel vs. the U.S. dollar, which had a positive effect on the shekel denominated tax provisions.
Liquidity and Capital Resources
ICL has long-term credit facilities of $1,100 million, of which $205 million were utilized as of March 31, 2021.
Outstanding Net Debt
As of March 31, 2021, ICL’s net financial liabilities amounted to $2,482 million, an increase of $64 million compared to December 31, 2020.
Dividend Distribution
In connection with ICL’s first quarter 2021 results, the Board of Directors declared a dividend of 5.25 cents per share, or approximately $67 million in the aggregate, which will be payable on June 16, 2021, to shareholders of record as of June 2, 2021.
About ICL
ICL Group LTD is a leading global specialty minerals and chemicals company that creates impactful solutions for humanity's sustainability challenges in global food, agriculture, and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its passionate team of talented employees, and its strong focus on R&D and technological innovation to drive growth across its end markets. ICL shares are dually listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 11,000 people worldwide, and its 2020 revenues totaled approximately $5.0 billion.
For more information, visit ICL's website at www.icl-group.com.
To access ICL's interactive Corporate Social Responsibility report, please click here.
You can also learn more about ICL on Facebook, LinkedIn and Instagram.
Guidance
(1a) The company only provides guidance on a non-GAAP basis. The company does not provide a reconciliation of forward-looking adjusted EBITDA (non-GAAP) to GAAP net income (loss), due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation, in particular because special items such as restructuring, litigation and other matters, used to calculate projected net income (loss) vary dramatically based on actual events, the company is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income (loss) at this time. The amount of these deductions may be material and, therefore, could result in projected GAAP net income (loss) being materially less than projected adjusted EBITDA (non-GAAP). The guidance speaks only as of the date hereof. We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Non-GAAP Statement
The company discloses in this quarterly announcement non-IFRS financial measures titled adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share and adjusted EBITDA. The management uses adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share and adjusted EBITDA to facilitate operating performance comparisons from period to period. The company calculates adjusted operating income by adjusting operating income to add certain items, as set forth in the reconciliation table under adjustments to reported operating and net income (non-GAAP). Certain of these items may recur. The company calculates adjusted net income attributable to the company’s shareholders by adjusting net income attributable to the company’s shareholders to add certain items, as set forth in the reconciliation table under adjustments to reported operating and net income (non-GAAP), excluding the total tax impact of such adjustments. The company calculates diluted adjusted earnings per share by dividing adjusted net income by the weighted-average number of diluted ordinary shares outstanding. The company calculates adjusted EBITDA by adding back to the net income attributable to the company’s shareholders the depreciation and amortization, financing expenses, net, taxes on income and the items presented in the reconciliation table under consolidated adjusted EBITDA and diluted adjusted earnings per share for the periods of activity (non-GAAP), which were adjusted for in calculating the adjusted operating income and adjusted net income attributable to the company’s shareholders. Other companies may calculate similarly titled non‑IFRS financial measures differently than the company.
You should not view adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share or adjusted EBITDA as a substitute for operating income or net income attributable to the company’s shareholders determined in accordance with IFRS, and you should note that the definitions of adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share and adjusted EBITDA may differ from those used by other companies. Additionally, other companies may use other measures to evaluate their performance, which may reduce the usefulness of ICL’s non-IFRS financial measures as tools for comparison. However, the company believes adjusted operating income, adjusted net income attributable to the company’s shareholders, diluted adjusted earnings per share and adjusted EBITDA provide useful information to both management and investors by excluding certain items management believes are not indicative of ongoing operations. Management uses these non-IFRS measures to evaluate the company's business strategies and management's performance. The company believes these non‑IFRS measures provide useful information to investors because they improve the comparability of financial results between periods and provide for greater transparency of key measures used to evaluate performance.
The company presents a discussion in the period-to-period comparisons of the primary drivers of changes in the results of operations. This discussion is based in part on management’s best estimates of the impact of the main trends on its businesses. The company has based the following discussion on its financial statements. You should read such discussion together with the financial statements.
Forward Looking Statements
This announcement contains statements that constitute forward‑looking statements, many of which can be identified by the use of forward‑looking words such as anticipate, believe, could, expect, should, plan, intend, estimate, strive, forecast, target, and potential, among others.
Forward‑looking statements appear in a number of places in this announcement and include, but are not limited to, our 2021 adjusted EBITDA guidance, statements regarding our intent, belief or current expectations. Forward‑looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and the actual results may differ materially from those expressed or implied in the forward‑looking statements due to various factors, including, but not limited to:
Changes in exchange rates or prices compared to those we are currently experiencing; loss or impairment of business licenses or mineral extractions permits or concessions; volatility of supply and demand and the impact of competition; the difference between actual reserves and our reserve estimates; natural disasters; failure to harvest salt, which could lead to accumulation at the bottom of evaporation Pond 5 in the Dead Sea; construction of a new pumping station; disruptions at our seaport shipping facilities or regulatory restrictions affecting our ability to export our products overseas; general market, political or economic conditions in the countries in which we operate; price increases or shortages with respect to our principal raw materials; delays in the completion of major projects by third party contractors and/or termination of engagements with contractors and/or governmental obligations; the inflow of significant amounts of water into the Dead Sea could adversely affect production at our plants; labor disputes, slowdowns and strikes involving our employees; pension and health insurance liabilities; the ongoing COVID-19 pandemic, which has impacted, and may continue to impact our sales, operating results and business operations by disrupting our ability to purchase raw materials, by negatively impacting the demand and pricing for some of our products, by disrupting our ability to sell and/or distribute products, impacting customers' ability to pay us for past or future purchases and/or temporarily closing our facilities or the facilities of our suppliers or customers and their contract manufacturers, or restricting our ability to travel to support our sites or our customers around the world; changes to governmental incentive programs or tax benefits, creation of new fiscal or tax related legislation; changes in our evaluations and estimates, which serve as a basis for the recognition and manner of measurement of assets and liabilities; higher tax liabilities; failure to integrate or realize expected benefits from mergers and acquisitions, organizational restructuring and joint ventures; currency rate fluctuations; rising interest rates; government examinations or investigations; disruption of our, or our service providers', information technology systems or breaches of our, or our service providers', data security; failure to retain and/or recruit key personnel; inability to realize expected benefits from our cost reduction program according to the expected timetable; inability to access capital markets on favorable terms; cyclicality of our businesses; changes in demand for our fertilizer products due to a decline in agricultural product prices, lack of available credit, weather conditions, government policies or other factors beyond our control; sales of our magnesium products being affected by various factors that are not within our control; our ability to secure approvals and permits from the authorities in Israel to continue our phosphate mining operations in Rotem; volatility or crises in the financial markets; uncertainties surrounding the proposed withdrawal of the United Kingdom from the European Union; hazards inherent to mining and chemical manufacturing; the failure to ensure the safety of our workers and processes; cost of compliance with environmental, regulatory, legislative, and licensing restrictions; laws and regulations related to, and physical impacts of climate change and greenhouse gas emissions; litigation, arbitration and regulatory proceedings; exposure to third party and product liability claims; product recalls or other liability claims as a result of food safety and food-borne illness concerns; insufficiency of insurance coverage; closing of transactions, mergers and acquisitions; war or acts of terror and/or political, economic and military instability in Israel and its region; filing of class actions and derivative actions against the Company, its executives and Board members; the company is exposed to risks relating to its current and future activity in emerging markets; and other risk factors discussed under Item 3 - Key Information - D. Risk Factors in the company's annual report on Form 20-F for the year ended December 31, 2020, filed with the U.S. Securities and Exchange Commission (SEC) on March 2, 2021 (the Annual Report).
Forward‑looking statements speak only as of the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.
This announcement for the first quarter of 2021 (herein after the quarterly announcement) should be read in conjunction with the annual report, including the description of the events occurring subsequent to the date of the statement of financial position, as filed with the SEC.
APPENDIX
Condensed Consolidated Statements of Income (Unaudited)
$ millions
Three-months ended
Year ended
March 31, 2021
March 31, 2020
December 31, 2020
1,510
1,319
5,043
Cost of sales
1,015
919
3,553
495
400
1,490
Selling, transport and marketing expenses
229
188
766
General and administrative expenses
62
64
232
Research and development expenses
15
14
54
Other expenses
5
2
256
Other income
(1)
-
(20)
185
132
202
Finance expenses
60
73
219
Finance income
(40)
(21)
(61)
Finance expenses, net
20
52
158
Share in earnings of equity-accounted investees
1
Income before income taxes
165
81
49
Provision for income taxes
23
25
Net income
142
61
24
Net income attributable to the non-controlling interests
7
13
Net income attributable to the shareholders of the Company
135
11
Earnings per share attributable to the shareholders of the Company:
Basic earnings per share (in dollars)
0.11
0.05
0.01
Diluted earnings per share (in dollars)
Weighted-average number of ordinary shares outstanding:
Basic (in thousands)
1,280,700
1,279,647
1,280,026
Diluted (in thousands)
1,282,912
1,280,168
1,280,273
Condensed Consolidated Statements of Financial Position as of (Unaudited)
Current assets
Cash and cash equivalents
157
434
214
Short-term investments and deposits
99
90
100
Trade receivables
1,056
939
883
Inventories
1,195
1,256
1,250
Other receivables
481
412
394
Total current assets
2,988
3,131
2,841
Non-current assets
Investments at fair value through other comprehensive income
83
Deferred tax assets
136
102
127
Property, plant and equipment
5,531
5,316
5,550
Intangible assets
709
652
670
Other non-current assets
356
247
393
Total non-current assets
6,732
6,417
6,823
Total assets
9,720
9,548
9,664
Current liabilities
Short-term debt
617
606
679
Trade payables
752
757
740
Provisions
43
Other payables
735
637
704
Total current liabilities
2,158
2,043
2,177
Non-current liabilities
Long-term debt and debentures
2,121
2,353
2,053
Deferred tax liabilities
320
336
326
Long-term employee liabilities
620
522
655
262
198
267
Other
75
98
Total non-current liabilities
3,398
3,471
3,399
Total liabilities
5,556
5,514
5,576
Equity
Total shareholders’ equity
4,000
3,903
3,930
Non-controlling interests
164
131
Total equity
4,164
4,034
4,088
Total liabilities and equity
Condensed Consolidated Statements of Cash Flows (Unaudited)
Adjustments for:
Depreciation and amortization
117
118
489
Impairment of fixed assets
Exchange rate, interest and derivatives, net
53
Tax expenses
Change in provisions
(25)
113
4
174
200
812
Change in inventories
30
28
Change in trade receivables
(147)
(186)
(89)
Change in trade payables
39
71
84
Change in other receivables
(9)
(6)
Change in other payables
(12)
Net change in operating assets and liabilities
(99)
(65)
108
Interests paid
(18)
(109)
Income taxes received (paid), net of refund
(10)
(31)
Net cash provided by operating activities
206
166
804
Cash flows from investing activities
Proceeds from deposits and investments, net
8
12
34
Business combinations
(64)
(27)
Purchases of property, plant and equipment, and intangible assets
(139)
(626)
Proceeds from divestiture of businesses net of transaction expenses
26
10
Net cash used in investing activities
(203)
(153)
(583)
Cash flows from financing activities
Dividends paid to the Company's shareholders
(34)
(23)
(118)
Receipt of long-term debt
310
1,175
Repayments of long-term debt
(311)
(143)
(1,133)
Repayments of short-term debt, net
(41)
(52)
Receipts (payments) from transactions in derivatives designated as a cash flow hedge
(16)
Net cash provided by (used in) financing activities
(62)
331
(105)
Net change in cash and cash equivalents
(59)
344
116
Cash and cash equivalents as of the beginning of the period
95
Net effect of currency translation on cash and cash equivalents
(5)
3
Cash and cash equivalents as of the end of the period
Consolidated EBITDA for the periods of activity
Net income attributable to shareholders of the company
Financing expenses, net
Taxes on income, net
Minority and equity income, net(1)
Minority and equity income, net(2)
(7)
Total EBITDA
295
250
(1) Calculated by deducting the share in earnings of equity-accounted investees and adding the net income attributable to non-controlling interests.
(2) Calculated by adding the share in earnings of equity accounted investees and deducting the net income attributable to non-controlling interests.
Calculation of Segment EBITDA
Segment profit
105
103
29
40
9
22
17
37
Segment EBITDA
122
120
66
94
58
19
View source version on businesswire.com: https://www.businesswire.com/news/home/20210505006141/en/
Investor Relations Contacts Peggy Reilly Tharp VP, Global Investor Relations +1-314-983-7665 Peggy.ReillyTharp@icl-group.com Dudi Musler Director, Investor Relations +972-3-684-4448 Dudi.Musler@icl-group.com Press Contact Adi Bajayo Scherf Communications +972-52-4454789 Adi@scherfcom.com
Source: ICL Group LTD
Multimedia Files: